ARCHIVES

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

This article is from The Cancer Letter archive.

Vol. 03 No. 40 | October 7, 1977

Download PDF Visit The Full Archive

Related Articles

Grant Applications Pour Into NCI, NIH; Downward Trend In Funding Due To Be Reversed In FY 1979

June 16, 1978

Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer

December 26, 2003

GSK HPV Vaccine Offers Protection From 4 HPV Types

April 27, 2007

Beckman Coulter Offers Immunoassay System.

July 27, 2001

Coalition Demands Role In Deciding spending will Target Healy, Broder, Chabner

October 16, 1992

Virus Program Report On Scientific Activities

August 15, 1975